1zei
From Proteopedia
| Line 4: | Line 4: | ||
|PDB= 1zei |SIZE=350|CAPTION= <scene name='initialview01'>1zei</scene>, resolution 1.9Å | |PDB= 1zei |SIZE=350|CAPTION= <scene name='initialview01'>1zei</scene>, resolution 1.9Å | ||
|SITE= | |SITE= | ||
| - | |LIGAND= <scene name='pdbligand= | + | |LIGAND= <scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=CRS:M-CRESOL'>CRS</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene> |
|ACTIVITY= | |ACTIVITY= | ||
|GENE= | |GENE= | ||
| + | |DOMAIN= | ||
| + | |RELATEDENTRY= | ||
| + | |RESOURCES=<span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1zei FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1zei OCA], [http://www.ebi.ac.uk/pdbsum/1zei PDBsum], [http://www.rcsb.org/pdb/explore.do?structureId=1zei RCSB]</span> | ||
}} | }} | ||
| Line 27: | Line 30: | ||
[[Category: Edwards, E J.]] | [[Category: Edwards, E J.]] | ||
[[Category: Whittingham, J L.]] | [[Category: Whittingham, J L.]] | ||
| - | [[Category: CL]] | ||
| - | [[Category: CRS]] | ||
| - | [[Category: ZN]] | ||
[[Category: chemical activity]] | [[Category: chemical activity]] | ||
[[Category: cross-link]] | [[Category: cross-link]] | ||
| Line 38: | Line 38: | ||
[[Category: metabolic role]] | [[Category: metabolic role]] | ||
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Mar 31 01:34:53 2008'' |
Revision as of 22:34, 30 March 2008
| |||||||
| , resolution 1.9Å | |||||||
|---|---|---|---|---|---|---|---|
| Ligands: | , , | ||||||
| Resources: | FirstGlance, OCA, PDBsum, RCSB | ||||||
| Coordinates: | save as pdb, mmCIF, xml | ||||||
CROSS-LINKED B28 ASP INSULIN
Overview
Insulin's natural tendency to form dimers and hexamers is significantly reduced in a mutant insulin B28 Pro --> Asp, which has been designed as a monomeric, rapid-acting hormone for therapeutic purposes. This molecule can be induced to form zinc hexamers in the presence of small phenolic derivatives which are routinely used as antimicrobial agents in insulin preparations. Two structures of B28 Asp insulin have been determined from crystals grown in the presence of phenol and m-cresol. In these crystals, insulin exists as R6 zinc hexamers containing a number of phenol or m-cresol molecules associated with aromatic side chains at the dimer-dimer interfaces. At the monomer-monomer interfaces, the B28 Pro --> Asp mutation leads to increased conformational flexibility in the B chain C termini, resulting in the loss of important intermolecular van der Waals contacts, thus explaining the monomeric character of B28 Asp insulin. The structure of a cross-linked derivative of B28 Asp insulin, containing an Ala-Lys dipeptide linker between residues B30 Ala and A1 Gly, has also determined. This forms an R6 zinc hexamer containing several m-cresol molecules. Of particular interest in this structure are two m-cresol molecules whose binding disrupted the beta-strand in one of the dimers. This observation suggests that the cross-link introduces mechanical strain on the B chain C terminus, thereby weakening the monomer-monomer interactions.
About this Structure
1ZEI is a Single protein structure of sequence from Sus scrofa. Full crystallographic information is available from OCA.
Reference
Interactions of phenol and m-cresol in the insulin hexamer, and their effect on the association properties of B28 pro --> Asp insulin analogues., Whittingham JL, Edwards DJ, Antson AA, Clarkson JM, Dodson GG, Biochemistry. 1998 Aug 18;37(33):11516-23. PMID:9708987
Page seeded by OCA on Mon Mar 31 01:34:53 2008
